Informações:
Falhas:
ID
15129
Descrição
Process Versus Outcomes Incentives for Lipid Management; ODM derived from: https://clinicaltrials.gov/show/NCT02246959
Link
https://clinicaltrials.gov/show/NCT02246959
Palavras-chave
Versões (1)
- 17/05/2016 17/05/2016 -
Transferido a
17 de maio de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Diabetes NCT02246959
Eligibility Diabetes NCT02246959
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes NCT02246959
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Diabetes | Cardiovascular Diseases | Myocardial Infarction | Cerebrovascular accident | Peripheral Vascular Diseases
Item
diabetes and/or history of cvd (defined as diagnosis with myocardial infarction, stroke, or peripheral vascular disease)
boolean
C0011847 (UMLS CUI [1])
C0007222 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
C0038454 (UMLS CUI [4])
C0085096 (UMLS CUI [5])
C0007222 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
C0038454 (UMLS CUI [4])
C0085096 (UMLS CUI [5])
Low density lipoprotein cholesterol measurement
Item
ldl greater than or equal to 130 mg/dl measured during screening of potential participants
boolean
C0202117 (UMLS CUI [1])
Hydroxymethylglutaryl-CoA Reductase Inhibitors Pharmaceutical Preparations
Item
a prescription filled for a statin medication within the last 12 months (derived from pharmacy records)
boolean
C0360714 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
Possession of drugs Ratio
Item
medication possession ratio (mpr) less than 80%.
boolean
C0556451 (UMLS CUI [1,1])
C0456603 (UMLS CUI [1,2])
C0456603 (UMLS CUI [1,2])
Age
Item
under 18 years old
boolean
C0001779 (UMLS CUI [1])
Medical contraindication Use of Hydroxymethylglutaryl-CoA Reductase Inhibitors | Hydroxymethylglutaryl-CoA Reductase Inhibitors Adverse effects | Myopathy
Item
a contraindication to further statin use or have suffered statin side effects, such as myopathy
boolean
C1301624 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C0360714 (UMLS CUI [1,3])
C0360714 (UMLS CUI [2,1])
C0879626 (UMLS CUI [2,2])
C0026848 (UMLS CUI [3])
C1524063 (UMLS CUI [1,2])
C0360714 (UMLS CUI [1,3])
C0360714 (UMLS CUI [2,1])
C0879626 (UMLS CUI [2,2])
C0026848 (UMLS CUI [3])
Unwilling Informed Consent
Item
will not or cannot give consent
boolean
C0558080 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,2])
Liver diseases | Liver function tests abnormal | Alanine aminotransferase measurement | Aspartate aminotransferase measurement
Item
a history of active liver disease or abnormal liver function tests on baseline screening [alanine aminotransferase (alt) or aspartate aminotransferase (ast) greater than 3x the upper limit of normal].
boolean
C0023895 (UMLS CUI [1])
C0151766 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201899 (UMLS CUI [4])
C0151766 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201899 (UMLS CUI [4])
Study Subject Participation Status
Item
participating in another clinical trial with related aims
boolean
C2348568 (UMLS CUI [1])
Comorbidity Life Threatening | Neoplasm Metastasis
Item
co-morbidities likely to lead to death within a short period (e.g. metastatic cancer)
boolean
C0009488 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2])
C2826244 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2])